Established in 2004, The Research Group of Lexington (TRG) is an independent research firm focused in partnering to develop medications for tomorrow. TRG was owned and operated by Neil R. Farris, MD, a respected member of the Lexington medical community for more than 30 years, until 2019 when Jennifer B Nichols, RN BSN, CCRP became the sole owner; she began her career with TRG in 2010 as the Nurse Coordinator.
Because of the ability to recruit qualified volunteers and produce reliable, quality data for clinical trials, TRG has been selected by numerous sponsors for a variety of important studies from Phase II through Phase IV. TRG has expertise in working with pharmaceutical companies such as: Boehringer Ingelheim, Lilly, Takeda, Forest, NovoNordisk, GlaxoSmithKline, Johnson & Johnson, Sanofi, Roche, Novartis, Bristol-Myers Squibb, Merck, Amgen, and many more. At times, studies involve the joint venture of Contract Research Organizations (CROs), for instance: Covance, Quintiles, PPD, Kendle, ICON, PRA, and RTI. TRG embraces working in conjunction with companies and partnering for successful trials and outcomes.
TRG is able to make use of central Institutional Review Boards (IRBs) and these include: Chesapeake, Compass, Quorum, Schulman, Sterling, or whomever the sponsor indicates. TRG welcomes the opportunity to collaborate with every sponsor on their imperative trials.
While monitoring at TRG, Clinical Research Associates (CRAs) from sponsoring institutions have:
Private patient rooms specifically for research procedures
Safe and minimally accessed patient and regulatory documents
Password-protected internet access (WiFi)
On-site regulatory and budgetary personnel
Daily monitored temperatures with alarm features
The availability and flexibility of our site staff
24-hour emergency phone number provided to all participants (1-859-351-3183)
Volunteers are acquired through the vast practice database which consists of six providers, the TRG database of potential and past study participants, direct mailings, health fairs, word of mouth, and advertising in the community and surrounding areas by means of radio, TV, online, and paper ads. Study participants are not required to be practice patients.
